Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "US"

10498 News Found

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
Technology | June 23, 2026

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows


Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition
Drug Approval | June 22, 2026

Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition

Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility


Piramal Pharma Solutions achieves 200+ customer audits, 70 regulatory approvals in FY26
News | June 22, 2026

Piramal Pharma Solutions achieves 200+ customer audits, 70 regulatory approvals in FY26

CDMO strengthens global quality framework through digital transformation, AI-enabled investigations, workforce development and continuous audit readiness


Univar expands EMEA reach in botanical ingredients push with American Distilling partnership
Supply Chain | June 21, 2026

Univar expands EMEA reach in botanical ingredients push with American Distilling partnership

The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets


LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
News | June 21, 2026

LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy

The collaboration is focused on overcoming a major limitation in existing cancer drugs


FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
Drug Approval | June 21, 2026

FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens

The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections


Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market
News | June 20, 2026

Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market

Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq


Alembic Pharma receives USFDA tentative approval for Binimetinib tablets
Drug Approval | June 20, 2026

Alembic Pharma receives USFDA tentative approval for Binimetinib tablets

Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market


Automated cell therapy manufacturing attracts US$1.1 Billion  across 34 funding rounds
Biopharma | June 20, 2026

Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds

New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones


Govt pushes for identifying every missing TB case
Policy | June 20, 2026

Govt pushes for identifying every missing TB case

Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline